HAIFA BAY, Israel (AP) _ Taro Pharmaceutical Industries Ltd. (TARO) on Monday reported fiscal third-quarter net income of $67.7 million.
The Haifa Bay, Israel-based company said it had profit of $1.76 per share.
The drug maker posted revenue of $147.7 million in the period.
Taro shares have declined slightly more than 9% since the beginning of the year. In the final minutes of trading on Monday, shares hit $79.65, a decline of 16% in the last 12 months.